Re: Not good for the potential of apabetalone as a Covid-19 therapy
in response to
by
posted on
Dec 02, 2021 12:05PM
I have to disagree with you there palidin. With MRK coming out just a couple of days ago saying their pill only works 30% of the time, the market potential for any other competitors just went up dramatically. We have heard of a number of other companies here in Canada that have had struggles getting their potential drugs through the unbelievable amount of red tape here. It is possible that APB could be facing those challenges here and now. Maybe there is some untold reason that the Kingdom of Morocco dealings were made public not to long ago.
Just my looking at things from a glass half full point of view.
tada